Home » Newsletters » BioWorld Science

BioWorld Science

June 17, 1997

View Archived Issues

La Jolla Cancer Res. Found. discloses integrin-binding peptides

Merck & Co. prepares improved inhibitors of protein farnesyltransferase

GABArho receptor antagonists described by University of California

Specific neuronal nicotinic cholinergic channel modulators from Abbott

Pliva prepares new macrolide antibiotics

Yamanouchi discloses new Na+/H+ exchange inhibitors

Compounds for urinary incontinence from Kyowa Hakko

Suntory prepares compounds for thrombocytopenia

Potent and selective beta3-adrenoceptor agonists claimed by Tokyo Tanabe

New vial size of generic leucovorin approved by FDA

Zonagen reports results of second phase III trial of Vasomax

Milkhaus receives FDA approval to start phase II cystic fibrosis trial

New asthma treatment now available in Canada

Proischemic effect of enalapril in MI

Neuroprotective effects of ZD-9379 in rat model

Cypros technology for prevention of organ transplant rejection covered under U.S. patent

Interferon/ribavirin compared to interferon and ribavirin monotherapy in chronic hepatitis C

Centocor's tumor marker assay now available for use in the U.S.

FDA advisory on AIDS drugs

3-Dimensional Pharmaceuticals licenses thrombin inhibitors to Wyeth-Ayerst

Preliminary phase III results with CellPro stem cell concentration product

Promising phase III data presented for Thyrogen in management of thyroid cancer patients

NIH-supported study evaluates efficacy and safety of acellular pertussis vaccine in adults

AWARE Rapid HIV Test equivalent to ELISA and Western blot tests

Apotex forms alliance for generic products in France

Tularik granted U.S. patent covering screens for nucleic acid polymerase inhibitors

VIMRx and Baxter to form new cell therapy company

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...